BSEInsider Trading / SAST3d ago · 22 Sept 2026, 11:13 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Essix Biosciences Ltd & Others
Ind-Swift Laboratories Ltd · 532305
✦ AI SummaryRegulatory
Ind-Swift Laboratories Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Essix Biosciences Ltd and others.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern2/10
Regulatory Risk6/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ind-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011